Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Annaleigh Benton
Annaleigh Benton

This Article

  1. Published in Advance February 26, 2026, doi: 10.1261/rna.080706.125 RNA 32: 812-826

Current Issue

  1. July 2026, 32 (7)
  1. Current Issue
  1. Alert me to new issues of RNA